Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Advanced Ultrasound Technology Helps Drive First-Stick Success for IV Insertions

By HospiMedica International staff writers
Posted on 12 Apr 2023

A majority of hospitalized patients, over 90%, receive IV therapy through a peripheral IV catheter, accounting for hundreds of millions of patients annually. More...

However, around two-thirds of these patients have veins that are challenging to visualize and access, leading to multiple needlesticks, vessel damage, and infiltration into surrounding tissue. Studies suggest that combining a needle-tracking system with ultrasound guidance may decrease the number of attempts and time needed for successful vessel access, potentially making vascular access procedures safer and more straightforward for both clinicians and patients. Now, a new advanced ultrasound device, featuring a specialized probe, has been developed to aid clinicians in achieving optimal IV placement.

The BD Prevue II System from Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) offers real-time needle depth markers, addressing a critical need in IV access. The system includes the BD Cue Needle Tracking System, which provides a high-quality ultrasound image of the needle's trajectory, and is compatible with BD Cue Needle Tracking-enabled catheters. The system's clinician-friendly features aim to broaden the use of ultrasound in IV placement. For instance, the BD Prevue II System's specialized probe is designed to minimize the learning curve, enabling clinicians to use the technology without altering their current insertion techniques or field of view.

The BD Prevue II System supports BD's "One-Stick Hospital Stay" vision, which aims to reduce unnecessary needlesticks by selecting the appropriate vascular access device and successfully placing it on the first try. This vision encompasses three key aspects: using one IV line as a single access point for required therapies and blood draws, maintaining the IV line optimally to reduce the risk of complications, and ensuring the IV line does not need to be replaced and lasts throughout a patient's hospital stay.

"Difficult IV access remains far too common today, but the availability of the BD Prevue II System supports a future where every needlestick has a predefined pathway for successful placement," said Eric Borin, worldwide president of Medication Delivery Solutions at BD. "BD is advancing the vision of a 'One-Stick Hospital Stay,' and first-stick success is the first requirement to fulfill that vision. First-stick success also reduces the pain and anxiety patients often experience while undergoing multiple IV access attempts and provides clinicians with IV workflow efficiencies and confidence."

Related Links:
BD 


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.